Advancing precision medicine with personalized drug screening.

Therapeutic Approaches

Abstract

Personalized drug screening (PDS) of approved drug libraries enables rapid development of specific small-molecule therapies for individual patients. With a multidisciplinary team including clinicians, researchers, ethicists, informaticians and regulatory professionals, patient treatment can be optimized with greater efficacy and fewer adverse effects by using PDS as an approach to find remedies. In addition, PDS has the potential to rapidly identify therapeutics for a patient suffering from a disease without an existing therapy. From cancer to bacterial infections, we review specific maladies addressed with PDS campaigns. We predict that PDS combined with personal genomic analyses will contribute to the development of future precision medicine endeavors.

Authors

Gorshkov, Kirill; Chen, Catherine; Marshall, Raisa E; Mihatov, Nino; Choi, Yong; Nguyen, Trung; Southall, Noel; Chen, Kevin G; Park, John K; Zheng, Wei;

External Links